ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
iShares Health Innovation Active ETF
33.32
+0.1042
0.31%
盤後:
33.32
0.0000
0.00%
16:10 EDT
成交量:
583
成交額:
1.94萬
市值:
1,332.60萬
市盈率:
- -
高:
33.32
開:
33.23
低:
33.23
收:
33.21
52周最高:
34.86
52周最低:
25.79
股本:
40.00萬
流通股本:
40.00萬
量比:
0.29
換手率:
0.15%
股息:
0.08
股息率:
0.24%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
健康快訊:一種用於磁共振成像檢查的新造影劑可更早發現肺癌
路透中文
·
2小時前
Contineum 股價下跌 9.9%,原因是其與強生合作研發的抗抑鬱藥中期臨床試驗失敗。
智通财经
·
3小時前
吉利德科學攜手巴西衞生部,共促Lenacapavir本地化生產新篇章
美股速递
·
昨天
吉利德科學:持續探索與泛美衞生組織合作,助力各國準備好並擴大長效艾滋病預防措施的普及
美股速递
·
昨天
吉利德科學公司高管在電話會議上表示,HIV藥物市場的增長預計將在未來幾個季度內迴歸至2%至3%的正常水平。
格隆汇
·
昨天
吉利德與泛美衞生組織就拉丁美洲和加勒比地區艾滋病預防藥物獲取問題達成一致
路透中文
·
昨天
吉利德科學攜手泛美衞生組織,加速拉美及加勒比地區HIV預防藥物Lenacapavir的可及性
美股速递
·
昨天
吉利德高管表示,未來幾個季度HIV市場增長或將回歸2%-3%常態水平
美股速递
·
昨天
吉利德高管透露:周服HIV預防藥物有望2027年第一季度上市
美股速递
·
昨天
實時行情-紐約之秋:製造業擴張放緩,投入成本創數年新高——紐約聯儲
路透中文
·
昨天
實時行情-受油價和債券收益率飆升影響,美國股市指數回落
路透中文
·
昨天
實時行情-受油價和債券收益率飆升影響,美國股市指數回落
路透中文
·
昨天
市場消息:美國食品藥品監督管理局啓動加速新藥臨床試驗申請試點項目,開始受理相關申請。
智通财经
·
昨天
石藥創新:SYS6010再獲突破性治療認定 III期臨床試驗正在開展
同花顺
·
昨天
恒瑞醫藥:子公司「注射用瑞卡西單抗」獲批開展III期臨床試驗
财中社
·
昨天
可以多活8.2個月!國產雙抗挑戰全球腫瘤「藥王」總生存期勝出
第一财经
·
昨天
恒瑞醫藥(600276.SH):HRS-4139片獲得藥物臨床試驗批准通知書
智通财经
·
昨天
恒瑞醫藥:子公司HRS-4139片獲臨床試驗批准
智通财经
·
昨天
恒瑞醫藥:瑞卡西單抗獲批開展III期臨床試驗
智通财经
·
昨天
維康藥業(300878.SZ):黃甲軟肝顆粒獲批開展用於慢性乙型病毒性肝炎肝纖維化的III期臨床試驗
智通财经
·
昨天
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BMED/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.315,"timestamp":1789502400000,"preClose":33.2108,"halted":0,"volume":583,"hourTrading":{"tag":"盘后","latestPrice":33.315,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":199.89,"timestamp":1789503006991,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0031375335734158388,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"盤後交易","change":0.1042,"latestTime":"09-15 16:59:41 EDT","open":33.23,"high":33.315,"low":33.23,"amount":19399,"amplitude":0.002559,"askPrice":49.98,"askSize":200,"bidPrice":17.52,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":33.2108,"sharesOutstanding":360000,"nav":32.890304,"aum":13156121.6,"dividendRate":0.002392,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.315,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":199.89,"timestamp":1789503006991,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.294683,"impliedVol":0.0634,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.294683,"shares":400000,"dividePrice":0.0797,"high":33.315,"amplitude":0.002559,"preClose":33.2108,"low":33.23,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.315,"committee":-0.333333,"eps":0,"divideRate":0.002392,"volume":583,"delay":0,"ttmEps":0,"open":33.23,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":33.33,"twentyDayClose":32.4416,"sixtyDayClose":28.4203},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667621189","title":"健康快訊:一種用於磁共振成像檢查的新造影劑可更早發現肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621189","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621189?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 02:52","pubTimestamp":1789498325,"startTime":"0","endTime":"0","summary":"健康快讯:一种用于磁共振成像检查的新造影剂可更早发现肺癌《Health Rounds》荣获2026年出版商通讯奖“最佳科学通讯”奖项,每周二和周四发布。今天我们重点介绍一种可能改变游戏规则的磁共振成像实验性造影剂,它有望在肺癌肿瘤尚小、治疗选择更多时就发现病灶。新型造影剂可在MRI检查中发现微小肺部肿瘤研究人员发现,一种用于磁共振成像检查的新型造影剂,可能使医生在比目前更早的阶段诊断出肺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4S4571FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","IHE","LU2487616109.SGD","PJP","LU0058720904.USD","IE0002141913.USD","IE00BLSP4239.USD","LU0466842654.USD","BK4585","FHLC","LU0964807845.USD","IE000M9KFDE8.USD","LU2471134796.USD","RXL","JDOC","LU1043141396.HKD","TRUH","MEDX","LU0820561818.USD","BMED","LU1674673428.USD","LU0072461881.USD","LU0345770308.USD","BK4592","LU1244550221.USD","IE00B1BXHZ80.USD","LU0912757837.SGD","BK4581","IYH","XLV","FTXH","LU2468319806.SGD","IXJ","LU1629891620.HKD","IE00B4R5TH58.HKD","IE0001KFT4U8.USD","LU1732799900.SGD","LU0345770993.USD","LU1043141123.HKD","VHT","LU0203345920.USD","GDOC","SG9999001176.USD","IE000MB6IJN5.SGD","LU1267930813.SGD","LU2602419157.SGD","LU0545562505.USD","JNJ","BK4568","LU1221951129.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667296846","title":"Contineum 股價下跌 9.9%,原因是其與強生合作研發的抗抑鬱藥中期臨床試驗失敗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667296846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667296846?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:17","pubTimestamp":1789492646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IYH","IE00BFXG1179.USD","LU0689626769.HKD","LU1162221912.USD","LU1989771016.USD","BMED","LU0345769631.USD","LU0203345920.USD","LU1430594728.SGD","LU2468319806.SGD","BK4568","LU1032955483.USD","IE00B42XCP33.USD","MDTX","IE00BJT1NW94.SGD","PJP","FHLC","IE00BFTCPJ56.SGD","JNJ","LU0124676726.USD","LU2403377893.USD","XLV","LU0432979614.USD","LU0820561818.USD","MEDX","LU0072461881.USD","LU1929549753.HKD","TRUH","IE00B19Z3B42.SGD","LU0792757196.USD","FTXH","IBBQ","LU0545562505.USD","GDOC","LU0889566641.SGD","LU2417539215.USD","LU1228905540.USD","LU1629891620.HKD","IBBJ","IHE","RXL","IE000SO60NU8.SGD","LU0289739699.SGD","VHT","PSYK","JDOC","LU1585245621.USD","LU1244550577.SGD","IXJ","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120765496","title":"吉利德科學攜手巴西衞生部,共促Lenacapavir本地化生產新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120765496?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露,正积极与巴西卫生部探索合作良机,旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措,无疑为巴西医药产业自主化进程注入了强劲动力。据悉,双方的洽谈聚焦于如何深化协作,以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir,作为一款备受瞩目的长效抗逆转录病毒药物,其本地化生产若能落地,对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0114720955.EUR","IE00BSNM7G36.USD","BK4139","BK4583","LU1023059063.AUD","LU0289739699.SGD","LU0965509283.SGD","LU1066051498.USD","LU1778281490.HKD","LU0859254822.USD","LU1430594728.SGD","MEDI","LU0320765992.SGD","LU0965509101.SGD","LU2357627491.SGD","SG9999015986.USD","IE00B19Z3581.USD","IE00B3T34201.USD","LU2089984988.USD","BBH","LU2468319806.SGD","GILD","BK4568","LU0122379950.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","BK4585","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU1934455277.USD","LU1585245621.USD","LU0109394709.USD","BK4550","LU0058720904.USD","LU0882574055.USD","LU1934455863.HKD","TMED","LU1061106388.HKD","LU1934455194.USD","LU0965508806.USD","TBXU","LU1674673691.USD","BK4566","LU1066053197.SGD","LU1037948897.HKD","LU0234570918.USD","LU0965509010.AUD","LU0823416689.USD","LU1037948541.HKD","IBBQ","BIB","LU0889565916.HKD","LU1839511570.USD","SG9999015952.SGD","BK4532","BMED","IE00B7SZLL34.SGD","LU0861579265.USD","SG9999015978.USD","LU2087621335.USD","BK4578","IE0002270589.USD","LU2112291526.USD","LU2324357040.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158863992","title":"吉利德科學:持續探索與泛美衞生組織合作,助力各國準備好並擴大長效艾滋病預防措施的普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1158863992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158863992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485330,"startTime":"0","endTime":"0","summary":"吉利德科学(Gilead Sciences)宣布,将继续探索与泛美卫生组织(PAHO)的合作机会,以支持各国做好充分准备,并推动长效艾滋病预防手段的可及性扩展。这一举措旨在强化全球公共卫生应对体系,尤其是针对中低收入国家的需求,通过技术转移、能力建设及供应链优化等途径,加快长效预防方案的落地与规模化应用。双方的合作重点在于应对实施层面的挑战,确保相关资源能够高效、公平地分配至最需要的人群,从而在更大范围内遏制HIV的传播。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","BK4550","LU0823416689.USD","IE00B3T34201.USD","LU1430594728.SGD","SG9999015945.SGD","BBH","BK4139","BK4588","LU0109394709.USD","LU0320765992.SGD","LU1571399168.USD","IBBQ","LU0965509283.SGD","LU1585245621.USD","MEDI","LU2089984988.USD","BK4578","SG9999015986.USD","LU1066051498.USD","LU1839511570.USD","BK4583","LU0122379950.USD","LU2324357040.USD","LU1674673428.USD","SG9999015978.USD","LU0859254822.USD","LU0882574055.USD","LU0965509010.AUD","LU1057294990.SGD","LU1061106388.HKD","LU2468319806.SGD","LU2112291526.USD","BK4532","LU0965509101.SGD","BMED","LU1934455194.USD","LU1037948541.HKD","LU2357627491.SGD","IBB","LU1674673691.USD","BK4585","TBXU","LU0861579265.USD","LU0234570918.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1037948897.HKD","LU1934455277.USD","BK4568","LU0889565916.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","LU2087621335.USD","LU1934455863.HKD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","BIB","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","TMED","LU0058720904.USD","IE00BSNM7G36.USD","GILD","BK4566","LU0965508806.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623020","title":"吉利德科學公司高管在電話會議上表示,HIV藥物市場的增長預計將在未來幾個季度內迴歸至2%至3%的正常水平。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623020","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623020?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:11","pubTimestamp":1789485099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0859254822.USD","IE0002270589.USD","TBXU","BK4550","LU1057294990.SGD","LU1066051498.USD","LU1839511570.USD","IBBQ","LU0234570918.USD","LU0965509283.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU2112291526.USD","SG9999015978.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU1934455277.USD","BK4532","LU2324357040.USD","LU0289739699.SGD","BMED","BK4566","IBB","BK4568","LU0965509101.SGD","BIB","LU1066053197.SGD","BK4139","GILD","LU1037948897.HKD","LU1585245621.USD","LU1674673691.USD","LU0320765992.SGD","LU0882574055.USD","LU0058720904.USD","LU1674673428.USD","TMED","LU0114720955.EUR","SG9999015952.SGD","LU1061106388.HKD","LU1037948541.HKD","SG9999015945.SGD","LU0965509010.AUD","BK4588","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","MEDI","BBH","LU1430594728.SGD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062306","title":"吉利德與泛美衞生組織就拉丁美洲和加勒比地區艾滋病預防藥物獲取問題達成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062306","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062306?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485029,"startTime":"0","endTime":"0","summary":"吉利德与泛美卫生组织就拉丁美洲和加勒比地区艾滋病预防药物获取问题达成一致路透9月15日-美国制药公司吉利德科学GILD.O周二表示,已与泛美卫生组织达成协议,将在拉丁美洲和加勒比地区扩大其艾滋病预防药物的可及性,以帮助这些地区遏制新发感染。吉利德公司指出,2010年至2024年间,拉丁美洲和加勒比地区的新发艾滋病毒感染病例增加了13%,并归因于艾滋病毒预防药物使用方面的缺口。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T45714A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","BK4568","LU2324357040.USD","MEDI","BK4139","LU0965509010.AUD","LU1057294990.SGD","BK4550","IE00B19Z3B42.SGD","LU0114720955.EUR","LU1585245621.USD","TBXU","LU1066051498.USD","BBH","IE00BKVL7J92.USD","LU0058720904.USD","IE0002270589.USD","IBB","LU1037948897.HKD","LU0859254822.USD","SG9999015945.SGD","LU0122379950.USD","SG9999015952.SGD","LU1934455277.USD","SG9999015978.USD","LU0965509101.SGD","LU2112291526.USD","LU0965509283.SGD","LU0889565916.HKD","LU1934455863.HKD","LU0320765992.SGD","IBBQ","TMED","LU1674673691.USD","BMED","IE00B19Z3581.USD","BK4588","LU1037948541.HKD","LU1839511570.USD","BIB","LU0882574055.USD","LU1066053197.SGD","GILD","BK4532","LU0234570918.USD","LU1674673428.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU0289739699.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159280995","title":"吉利德科學攜手泛美衞生組織,加速拉美及加勒比地區HIV預防藥物Lenacapavir的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1159280995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159280995?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485009,"startTime":"0","endTime":"0","summary":"吉利德科学(Gilead Sciences)日前宣布,与泛美卫生组织(PAHO)达成一项战略合作。此番联手,旨在显著提升一年两针的HIV预防药物Lenacapavir在拉丁美洲及加勒比地区的可及性。双方的合作,将为该区域的高风险人群带来更便捷的预防选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU2324357040.USD","LU0114720955.EUR","MEDI","SG9999015978.USD","LU1430594728.SGD","BIB","IE00B19Z3581.USD","LU1839511570.USD","GILD","LU2089984988.USD","LU1037948541.HKD","LU0965509101.SGD","LU0289739699.SGD","LU2112291526.USD","BK4566","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IBBQ","LU1037948897.HKD","BK4578","SG9999015986.USD","LU0965508806.USD","LU2468319806.SGD","LU2087621335.USD","LU2357627491.SGD","BK4139","LU1023059063.AUD","LU0320765992.SGD","LU0882574055.USD","LU1934455277.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0122379950.USD","LU0234570918.USD","LU1778281490.HKD","BK4568","LU0889565916.HKD","LU0058720904.USD","LU1674673691.USD","BK4550","LU1061106388.HKD","LU1571399168.USD","BMED","LU1066053197.SGD","IE00B3T34201.USD","IE0002270589.USD","BBH","IE00BKVL7J92.USD","LU1934455863.HKD","BK4585","TBXU","TMED","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0109394709.USD","LU0823416689.USD","LU1057294990.SGD","LU0859254822.USD","SG9999015945.SGD","BK4588","LU1674673428.USD","LU1934455194.USD","IBB","BK4532","LU0965509010.AUD","SG9999015952.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153389014","title":"吉利德高管表示,未來幾個季度HIV市場增長或將回歸2%-3%常態水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1153389014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153389014?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:09","pubTimestamp":1789484948,"startTime":"0","endTime":"0","summary":"吉利德高管在电话会议中透露,该公司预计HIV治疗市场的增长势头将在未来几个季度内逐步趋于稳定,最终回到2%至3%的年增长区间。这一表态正值市场对HIV药物需求持续波动的关键节点。高管指出,当前的增长水平仍高于长期趋势,但随着时间推移,这种偏热的状态将逐渐降温。整个行业的扩张速度,预计将在近期内回落至更为可持续的轨道上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0859254822.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","IBB","IE00B19Z3581.USD","LU0965509101.SGD","BBH","BK4585","LU1778281490.HKD","BIB","LU1037948897.HKD","SG9999015945.SGD","BK4583","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1674673428.USD","TBXU","LU2324357040.USD","LU1839511570.USD","LU1934455277.USD","BK4139","BK4568","LU1023059063.AUD","SG9999015986.USD","LU0234570918.USD","BK4588","IE00B3T34201.USD","BK4578","LU1934455194.USD","MEDI","LU2112291526.USD","SG9999015978.USD","SG9999015952.SGD","BMED","LU0122379950.USD","LU0109394709.USD","LU1061106388.HKD","LU1066051498.USD","LU0058720904.USD","LU0861579265.USD","LU2089984988.USD","LU0965508806.USD","TMED","LU1585245621.USD","GILD","IE0002270589.USD","LU0882574055.USD","LU0289739699.SGD","LU0114720955.EUR","BK4532","IE00B7SZLL34.SGD","BK4566","LU2087621335.USD","LU0965509010.AUD","LU1674673691.USD","LU1066053197.SGD","LU0320765992.SGD","LU0889565916.HKD","LU1934455863.HKD","LU0823416689.USD","LU1057294990.SGD","LU2468319806.SGD","LU2357627491.SGD","BK4550","LU1571399168.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131138631","title":"吉利德高管透露:周服HIV預防藥物有望2027年第一季度上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1131138631","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131138631?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:05","pubTimestamp":1789484737,"startTime":"0","endTime":"0","summary":"吉利德科学高管在电话会议中表示,其每周口服HIV预防药物预计将于2027年第一季度正式推出。这一表态为公司抗艾药物管线注入了新的期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0058720904.USD","BK4139","BIB","LU0965509283.SGD","TBXU","LU2324357040.USD","BK4550","IE00BSNM7G36.USD","LU0114720955.EUR","LU0234570918.USD","LU0289739699.SGD","LU1571399168.USD","IE00B7SZLL34.SGD","LU1066051498.USD","LU1037948541.HKD","LU0122379950.USD","LU1430594728.SGD","SG9999015986.USD","LU1061106388.HKD","LU0965508806.USD","LU2357627491.SGD","BK4578","BK4566","IE00B19Z3B42.SGD","LU0109394709.USD","LU1585245621.USD","SG9999015978.USD","BBH","LU1674673691.USD","LU1023059063.AUD","LU1066053197.SGD","LU0889565916.HKD","LU1934455277.USD","IE00BKVL7J92.USD","LU2089984988.USD","BK4532","BK4568","LU0320765992.SGD","LU1057294990.SGD","LU0861579265.USD","LU1934455194.USD","IE00B3T34201.USD","LU0823416689.USD","IBB","LU1674673428.USD","LU1934455863.HKD","BK4588","IE00B19Z3581.USD","LU2087621335.USD","LU2112291526.USD","LU2468319806.SGD","SG9999015952.SGD","BMED","IE0002270589.USD","LU1037948897.HKD","IBBQ","LU0882574055.USD","LU0965509010.AUD","SG9999015945.SGD","TMED","BK4585","BK4583","LU1839511570.USD","MEDI","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623990","title":"實時行情-紐約之秋:製造業擴張放緩,投入成本創數年新高——紐約聯儲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623990","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623990?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:53","pubTimestamp":1789484014,"startTime":"0","endTime":"0","summary":"实时行情-纽约之秋:制造业扩张放缓,投入成本创数年新高——纽约联储美国主要股指收跌;道指领跌,跌幅约1%可选消费品板块是标普500指数中表现最差的板块;能源板块是唯一上涨的板块欧洲STOXX 600指数下跌约0.4%美元小幅走强;美国原油上涨约2.8%;黄金回落;比特币下跌>4%美国10年期国债收益率触及5.041%,创2007年以来新高,目前约为5.00%9月15日-欢迎来到路透记者为您带来的实时市场报道专区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4S45713M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU1674673428.USD","LU0466842654.USD","LU0345770993.USD","LU0882574055.USD","LU2089984988.USD","LU0203347892.USD","LU0053666078.USD","JDOC","FHLC","BMED","LU1043141396.HKD","LU2505996681.GBP","IE00B42XCP33.USD","LU1066053197.SGD","MEDX","IE00BVYPNV92.GBP","LU0072461881.USD","FTXH","GDOC","LU0792757196.USD","XLV","LU1551013342.USD","LU2403377893.USD","TRUH","PJP","LU0210528500.USD","IXJ","BK4588","RXL","LU0320765646.SGD","LU0114720955.EUR","IE00BBT3K403.USD","IE00B3T34201.USD","CTNM","IE00BLSP4452.SGD","VHT","LU2417539215.USD","LU1023059063.AUD","LU1989771016.USD","JNJ","LU1551013425.SGD","IHE","IE00BJT1NW94.SGD","LU1935042991.SGD","LU0511384066.AUD","SGXZ57979304.SGD","LU2750360641.GBP","SGXZ80539844.SGD","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628768","title":"實時行情-受油價和債券收益率飆升影響,美國股市指數回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628768?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:28","pubTimestamp":1789482483,"startTime":"0","endTime":"0","summary":"实时行情-受油价和债券收益率飙升影响,美国股市指数回落美国主要股指全线走低;道指领跌,跌幅约1%可选消费品板块是标普500指数中表现最弱的板块;能源板块是唯一上涨的板块欧洲STOXX 600指数下跌约0.2%美元小幅走强;美国原油上涨>2%;黄金小幅回落;比特币下跌>3%美国10年期国债收益率一度触及5.041%,创2007年以来新高,目前约为5.01%9月15日-欢迎来到路透记者为您带来的市场实时报导专区。受此影响,康蒂尼姆股价暴跌逾11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T45711Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","IE000BZT7R73.USD","LU2236285917.USD","IHE","VHT","IE00BZ1G4Q59.USD","LU2487616109.SGD","MEDX","IXJ","LU0345769128.USD","JDOC","SG9999001176.SGD","LU2505996509.AUD","LU2592432038.USD","LU0203347892.USD","TRUH","FHLC","LU0057025933.USD","LU0795875169.SGD","LU1228905037.USD","LU2471134952.CNY","RXL","IE00BLSP4239.USD","BK4568","PJP","GDOC","BK4592","LU1059921491.USD","IE000F7OJYX1.SGD","LU2112291526.USD","LU1043141396.HKD","CTNM","LU1674673428.USD","LU2896262040.SGD","SG9999002224.SGD","LU2471134523.USD","JNJ","FTXH","LU2456880835.USD","LU1066051811.HKD","BMED","LU0820562030.AUD","IYH","XLV","LU1585245621.USD","LU1145028129.USD","LU1221951129.SGD","LU2417539215.USD","IE00BVYPNV92.GBP","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628763","title":"實時行情-受油價和債券收益率飆升影響,美國股市指數回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628763","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628763?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:28","pubTimestamp":1789482483,"startTime":"0","endTime":"0","summary":"实时行情-受油价和债券收益率飙升影响,美国股市指数回落美国主要股指全线走低;道指领跌,跌幅约1%可选消费品板块是标普500指数中表现最弱的板块;能源板块是唯一上涨的板块欧洲STOXX 600指数下跌约0.2%美元小幅走强;美国原油上涨>2%;黄金小幅回落;比特币下跌>3%美国10年期国债收益率一度触及5.041%,创2007年以来新高,目前约为5.01%9月15日-欢迎来到路透记者为您带来的市场实时报道专区。受此影响,康蒂尼姆股价暴跌逾11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4S45711Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996509.AUD","JNJ","VHT","BK4568","GDOC","LU1145028129.USD","LU2417539215.USD","LU0203347892.USD","LU2468319806.SGD","LU2487616109.SGD","LU1585245621.USD","FTXH","IXJ","BK4592","RXL","LU2112291526.USD","LU1043141396.HKD","LU2896262040.SGD","LU2456880835.USD","PJP","LU0345769128.USD","IYH","LU0057025933.USD","MEDX","LU2471134523.USD","SG9999001176.SGD","FHLC","CTNM","LU2236285917.USD","XLV","LU0795875169.SGD","IE000F7OJYX1.SGD","LU1228905037.USD","JDOC","IHE","LU1059921491.USD","LU2592432038.USD","LU1066051811.HKD","LU0820562030.AUD","IE000BZT7R73.USD","SG9999002224.SGD","TRUH","IE00BVYPNV92.GBP","LU1221951129.SGD","IE00BLSP4239.USD","LU1674673428.USD","LU0820561818.USD","IE00BZ1G4Q59.USD","BMED","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667362891","title":"市場消息:美國食品藥品監督管理局啓動加速新藥臨床試驗申請試點項目,開始受理相關申請。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667362891","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667362891?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:09","pubTimestamp":1789481392,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","PSYK","BMED","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264193","title":"石藥創新:SYS6010再獲突破性治療認定 III期臨床試驗正在開展","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264193","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264193?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:08","pubTimestamp":1789470480,"startTime":"0","endTime":"0","summary":"中证智能财讯石药创新(300765)9月15日晚间公告,公司控股子公司石药集团巨石生物制药有限公司开发的SYS6010被国家药品监督管理局药品审评中心纳入突破性治疗品种名单,拟定适应症为免疫及含 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260915/c679932866.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260915/c679932866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["IBBJ","BK0226","MDTX","300765","IBBQ","BMED","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648964","title":"恒瑞醫藥:子公司「注射用瑞卡西單抗」獲批開展III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648964","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:55","pubTimestamp":1789462500,"startTime":"0","endTime":"0","summary":"9月15日,恒瑞医药(600276/01276)发布公告,公司子公司广东恒瑞药有限公司近日收到国家药品监督管理局核准签发的关于注射用瑞卡西单抗的《药物临床试验批准通知书》,将于近期开展III期临床试验。该药物的适应症为颅内动脉粥样硬化性狭窄的成人患者,以降低卒中复发风险。2026年中期,恒瑞医药实现收入154.56亿元,归母净利润44.65亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153874740380.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153874740380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBBQ","600276","LU1820825898.SGD","LU0359201612.USD","BK0196","BK0012","BK0239","LU2488822045.USD","BK0060","LU0405327494.USD","LU2328871848.SGD","LU1997245094.SGD","BK0183","LU0359202008.SGD","LU2495084118.USD","LU2580892789.USD","LU0359201885.HKD","BMED","LU1655091616.SGD","IBBJ","PSYK","LU2097828805.USD","LU1969619763.USD","LU1997244956.HKD","LU1781817850.SGD","LU1328615791.USD","LU2097828714.EUR","LU1146622755.USD","LU2289578879.USD","BK0028","LU1064131003.USD","LU1023057109.AUD","BK0188","LU2148510915.USD","BK1191","LU0405327148.USD","LU2543165471.USD","LU1255011170.USD","LU2580892862.HKD","MDTX","LU2097828631.EUR","LU1997245177.USD","LU2097828557.USD","LU1580142542.USD","LU1064130708.USD","LU2097828474.EUR","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648612","title":"可以多活8.2個月!國產雙抗挑戰全球腫瘤「藥王」總生存期勝出","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648612","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648612?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:46","pubTimestamp":1789461960,"startTime":"0","endTime":"0","summary":"2026年世界肺癌大会,对于国产创新药而言,不只是“被看见”,更要回答一个硬核的问题:到底能不能让患者活得更久。继翰森制药ADC药物刷新全球小细胞肺癌二线治疗最长总生存期(OS)纪录外,另外一款国产创新药挑战全球肿瘤“药王”总生存期的数据也揭晓了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153874734252.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153874734252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2461242641.AUD","LU1934455863.HKD","LU1989772923.USD","KURE","LU2023250843.SGD","IE00B4R5TH58.HKD","LU2476274720.SGD","LU0823416689.USD","LU1961090484.USD","SG9999002232.USD","09926","LU0477156953.USD","LU0348783233.USD","SG9999001176.SGD","LU0965508806.USD","LU0348825331.USD","LU2361044865.SGD","LU2399975544.HKD","LU2360032135.SGD","SG9999002224.SGD","BK4533","IE00BBT3K403.USD","LU0289739343.SGD","LU1989771016.USD","LU0208291251.USD","LU1941712348.USD","FHLC","LU0070302665.USD","LU0634319403.HKD","SG9999001440.SGD","LU1032466523.USD","MRK","GDOC","XLV","LU0348735423.USD","VHT","IE00BFTCPJ56.SGD","LU2488822045.USD","LU2778985437.USD","LU1116320901.HKD","IE00BLSP4452.SGD","BK4559","LU0098860793.USD","LU0122379950.USD","LU1023059063.AUD","PPH","LU1116320737.USD","LU0472753341.HKD","LU1066051225.USD","IE00B543WZ88.USD","LU0980610538.SGD","LU0130517989.USD","IE00BLSP4239.USD","LU1093756168.USD","LU1035773651.USD","LU2125154778.USD","LU2125909247.SGD","LU0417516902.SGD","LU0511384066.AUD","LU1162221912.USD","IE00B2B36J28.USD","LU1934455277.USD","LU0861579265.USD","RXL","BK4550","LU0203347892.USD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0124676726.USD","LU1571399168.USD","BMED","BK4585","LU1061106388.HKD","LU1989772840.SGD","IE00BSNM7G36.USD","LU1720050803.USD","IE00BPRC5H50.USD","LU0130102774.USD","LU0238689110.USD","LU1093756325.SGD","LU0868494617.USD","LU0868494708.USD","LU2125154935.USD","LU0289961442.SGD","LU0942090050.USD","SG9999001176.USD","LU0265550359.USD","PAWZ","IHE","IE0002141913.USD","LU0006306889.USD","LU0689626769.HKD","LU1923622614.USD","BK4516","LU0069063385.USD","LU0648001328.SGD","LU2361045086.USD","LU1585245621.USD","LU0965509010.AUD","LU1066051498.USD","LU0965509101.SGD","HRTS","LU0320765489.SGD","LU1941712264.USD","LU0348784397.USD","LU2023250504.SGD","LU0266013472.USD","LU1929549753.HKD","SG9999014559.SGD","LU2491050154.USD","LU0348767384.USD","BK4007","LU0106261372.USD","LU0417516738.SGD","LU0234572021.USD","LU0561508036.HKD","LU2491050071.SGD","SG9999014567.USD","LU1037948897.HKD","IXJ","LU0057025933.USD","LU1794554557.SGD","LU1983299246.USD","LU2361044949.HKD","LU0348766576.USD","IE000M9KFDE8.USD","LU2089984988.USD","LU1974910355.USD","LU0348827113.USD","LU2125909593.SGD","TRUH","JDOC","LU1066051811.HKD","LU2357627491.SGD","LU0320765646.SGD","SG9999015358.SGD","LU2491049909.HKD","LU1430594728.SGD","LU1201861249.SGD","IE00B1BXHZ80.USD","LU0211331839.USD","LU1291159041.SGD","LU2433249047.HKD","LU1917777945.USD","FTXH","LU0965509283.SGD","LU2468319806.SGD","LU2112291526.USD","LU0265550946.USD","IE00BJT1NW94.SGD","LU2324357040.USD","BK1574","LU1037948541.HKD","LU2106854487.HKD","BK1161","IE0009355771.USD","LU0985320562.USD","LU1057294990.SGD","LU0058720904.USD","LU1934455194.USD","SGXZ57979304.SGD","IYH","LU0289739699.SGD","LU0417516571.SGD","LU0203345920.USD","BK4534","LU2476274308.USD","LU0859254822.USD","LU1699723380.USD","BK4588","SG9999014575.USD","SG9999013999.USD","IE00B5MMRT66.SGD","SG9999015341.SGD","SG9999014542.SGD","LU1069347547.HKD","LU0540923850.HKD","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610471","title":"恒瑞醫藥(600276.SH):HRS-4139片獲得藥物臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610471","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610471?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:39","pubTimestamp":1789461583,"startTime":"0","endTime":"0","summary":"智通财经APP讯,恒瑞医药(600276.SH)发布公告,近日,公司子公司福建盛迪医药有限公司收到国家药品监督管理局核准签发关于HRS-4139片的《药物临床试验批准通知书》,将于近期开展临床试验。HRS-4139片是公司自主研发的1类新药,在动物模型中,可有效改善银屑病症状,抑制炎症反应。经查询,国内外暂无相同靶点药物获批上市。截至目前,HRS-4139片相关项目累计研发投入约2,040万元(未经审计)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","IBBQ","LU1997244956.HKD","LU2097828631.EUR","BMED","LU1064131003.USD","LU1997245094.SGD","LU1655091616.SGD","MDTX","BK0028","LU1328615791.USD","LU2097828557.USD","LU2495084118.USD","LU0359202008.SGD","LU1023057109.AUD","LU2328871848.SGD","01276","LU1580142542.USD","BK0239","BK0188","LU1146622755.USD","LU2148510915.USD","LU2289578879.USD","LU2097828714.EUR","LU0359201612.USD","LU2097828805.USD","LU1255011170.USD","BK0183","LU1820825898.SGD","LU2488822045.USD","LU1969619763.USD","LU2543165471.USD","LU1997245177.USD","PSYK","IBBJ","LU1064130708.USD","LU0405327148.USD","LU0359201885.HKD","LU2580892789.USD","BK0012","LU0405327494.USD","600276","BK0196","LU2097828474.EUR","LU2580892862.HKD","LU1781817850.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610193","title":"恒瑞醫藥:子公司HRS-4139片獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610193","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610193?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:35","pubTimestamp":1789461321,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","MDTX","PSYK","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667101906","title":"恒瑞醫藥:瑞卡西單抗獲批開展III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667101906","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667101906?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:35","pubTimestamp":1789461310,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PSYK","BMED","IBBQ","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832610","title":"維康藥業(300878.SZ):黃甲軟肝顆粒獲批開展用於慢性乙型病毒性肝炎肝纖維化的III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832610","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832610?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:15","pubTimestamp":1789460131,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维康药业(300878.SZ)发布公告,公司于近日收到国家药品监督管理局核准签发的黄甲软肝颗粒的《药物临床试验补充申请批准通知书》,经审查,黄甲软肝颗粒临床试验申请符合药品注册的有关要求,在进一步完善临床试验方案的基础上,同意开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300878","PSYK","BMED","IBBJ","IBBQ","BK0239","MDTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}